A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer.
Aaron R HansenJohn J ParkJermaine CowardBen MarkmanCharlotte LemechJames C KuoAmy PrawiraMichael P BrownSarwan BishnoiDusan KotasekR Matthew StrotherRasha CosmanRila SuYiding MaZenglian YueHui-Han HuRachel WuPeiqi LiArchie N TsePublished in: British journal of cancer (2023)
Clinicaltrials.gov (NCT03475251).